There currently are unsatisfactory results and no consensus about treatment in ocular chronic graft-versus-host disease
We performed a single-center prospective pilot study regarding topical application of an autologous platelet concentrate, which was lysed and then reconstituted as eyes drops
Survival rates of patients with ocular chronic graft-versus-host disease are similar to those with limited chronic graft-versus-host disease